HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael S Middleton Selected Research

Non-alcoholic Fatty Liver Disease

10/2023Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
1/2023MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials.
1/2023Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis.
11/2021Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
9/2020Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C).
1/2020Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial.
1/2020The relationship between liver triglyceride composition and proton density fat fraction as assessed by 1 H MRS.
1/2019Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
1/2019Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.
1/2019Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael S Middleton Research Topics

Disease

25Non-alcoholic Fatty Liver Disease
10/2023 - 08/2011
11Fibrosis (Cirrhosis)
01/2023 - 01/2015
5Liver Diseases (Liver Disease)
10/2023 - 12/2009
4Fatty Liver
10/2023 - 07/2009
2Inflammation (Inflammations)
01/2023 - 11/2021
2Obesity
01/2020 - 01/2019
2Rupture
05/2014 - 02/2002
2Breast Neoplasms (Breast Cancer)
05/2014 - 09/2006
1Weight Loss (Weight Reduction)
09/2020
1Pruritus (Itching)
01/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2020
1Alcoholic Fatty Liver
01/2019
1Overweight
10/2015
1Infections
01/2015
1Hypersensitivity (Allergy)
11/2014
1Wolman Disease (Wolman's Disease)
11/2014
1Nephrogenic Fibrosing Dermopathy
12/2009
1Renal Insufficiency (Renal Failure)
12/2009
1Congenital Abnormalities (Deformity)
02/2002
1Confusion (Bewilderment)
02/2002

Drug/Important Bio-Agent (IBA)

18Protons (Proton)IBA
01/2023 - 06/2014
8Biomarkers (Surrogate Marker)IBA
10/2023 - 06/2015
4SteamIBA
01/2020 - 07/2009
3Triglycerides (Triacylglycerol)IBA
01/2020 - 11/2014
3Alanine Transaminase (SGPT)IBA
01/2019 - 04/2010
2nasIBA
01/2023 - 01/2019
2IronIBA
01/2019 - 01/2015
2firsocostatIBA
12/2018 - 11/2018
1Pyridinolcarbamate (P23)IBA
01/2022
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2020
1cilofexorIBA
01/2020
1Bile Acids and Salts (Bile Acids)IBA
01/2020
1Insulin (Novolin)FDA Link
01/2019
1selonsertibIBA
01/2019
1SugarsIBA
01/2019
1Acetyl-CoA CarboxylaseIBA
12/2018
1Tissue Inhibitor of Metalloproteinase-1IBA
11/2018
1Cysteamine (Mercaptamine)FDA Link
01/2018
1gadolinium ethoxybenzyl DTPAFDA Link
01/2017
1ferumoxides (Feridex)FDA Link
01/2015
1CollagenIBA
01/2015
1Gadolinium DTPA (Magnevist)FDA Link
01/2015
1OxidesIBA
01/2015
1Transaminases (Aminotransferases)IBA
11/2014
1Cholesterol Esters (Cholesteryl Esters)IBA
11/2014
1EnzymesIBA
11/2014
1Sebelipase alfaIBA
11/2014
1LipidsIBA
11/2014
1TESIBA
08/2011
1EmulsionsIBA
08/2011
1Contrast MediaIBA
12/2009
1gadodiamide (Omniscan)FDA Link
12/2009
1GadoliniumIBA
12/2009
1Capsules (Microcapsules)IBA
02/2002
1SiliconesIBA
02/2002

Therapy/Procedure

1Aftercare (After-Treatment)
01/2018
1Intravenous Administration
01/2015
1Breast Implants (Breast Implant)
05/2014
1Transplantation
12/2009
1Mastectomy (Mammectomy)
09/2006
1Segmental Mastectomy (Lumpectomy)
09/2006